Emergency Department Visits for Medication-Related Events With vs Without Pharmacist Intervention
Authors:
- 1 June 2025
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 185 (6) , 669-678
Abstract
Importance: Medication-related events (MREs) are a frequent cause of emergency department (ED) visits and patient harm.Objective: To assess the efficacy of a pharmacist-led transition of care program in reducing ED visits related to the same MRE at 6 months compared with usual care.Design, Setting, and Participants: This prospective, open-label, parallel-group randomized clinical trial was conducted from November 2018 to July 2021 at the ED of Montpellier University Hospital, Montpellier, France, with a 6-month follow-up period. Adult patients with an MRE detected at ED admission were included. MREs included adverse drug events with or without misuse and medication nonadherence with unfavorable clinical evolution. End points were assessed blindly from the randomization arm. Data were analyzed from January 2022 to March 2024.Intervention: Participants were randomized to a pharmacist-led transition of care program or usual care. Usual care included the ED pharmacist carrying out a medication history. In the transition of care group, ED pharmacists additionally made a postdischarge telephone call to the general practitioner (GP) and community pharmacist, along with a letter, notifying them about MRE type, suspected medication, and management recommendations.Main Outcomes and Measures: The primary outcome was the proportion of patients with an ED visit for the same MRE at 6 months (same symptom and medication involved). Secondary outcomes included proportions of all-cause and MRE-related ED visits, hospitalizations, deaths, and medical office visits.Results: Among 330 patients analyzed, 187 (56.7%) were female, the median (IQR) age was 71 (50-83) years, and the median (IQR) home medications count was 6 (3-10). A total of 167 patients were randomized to the transition of care group and 163 to the control group. At 6 months, fewer participants in the transition of care group had ED visits related to the same MRE (5 [3.0%] vs 36 [22.1%]; risk difference [RD], −19.1 percentage points; 95% CI, −26.0 to −12.2; P < .001), all-cause ED visits (35 [21.0%] vs 57 [35.0%]; RD, −14.0 percentage points; 95% CI, −23.6 to −4.4), hospitalization related to the same MRE (3 [1.8%] vs 29 [17.8%]; RD, −16.0 percentage points; 95% CI, −22.2 to −9.8), and more GP office visits (88 of 158 [55.7%] vs 26 of 146 [17.8%]; RD, 37.9 percentage points; 95% CI, 28.0 to 47.8) and specialist office visits (67 of 158 [42.4%] vs 35 of 146 [24.0%]; RD, 18.4 percentage points; 95% CI, 8.1 to 28.8) related to the same MRE. All-cause hospitalization and death were similar between groups.Conclusions and Relevance: In this randomized clinical trial, a pharmacist-led transitional care intervention in the ED among patients with MRE significantly reduced ED visits and hospitalizations for the same MRE. If replicated in subsequent trials, this strategy offers a novel approach for reducing drug-related harms.Trial Registration: ClinicalTrials.gov Identifier: NCT03725046Keywords
This publication has 59 references indexed in Scilit:
- Promoting effective transitions of care at hospital discharge: A review of key issues for hospitalistsJournal of Hospital Medicine, 2007
- Deficits in Communication and Information Transfer Between Hospital-Based and Primary Care PhysiciansJAMA, 2007
- Repeat adverse drug reactions causing hospitalization in older Australians: a population‐based longitudinal study 1980–2003British Journal of Clinical Pharmacology, 2006
- Emergency Physician Recognition of Adverse Drug-related Events in Elder Patients Presenting to an Emergency DepartmentAcademic Emergency Medicine, 2005
- CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatmentSeminars in Radiation Oncology, 2003
- Adverse Drug Events in Ambulatory CareNew England Journal of Medicine, 2003
- Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency departmentAnnals of Emergency Medicine, 2001
- Suspected adverse drug events requiring emergency department visits or hospital admissionsEuropean Journal of Clinical Pharmacology, 1999
- Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group.1995
- Minimization: A new method of assigning patients to treatment and control groupsClinical Pharmacology & Therapeutics, 1974